In its second major partnership with a big pharma group, UK-based AI and multi-omics company Relation Therapeutics has agreed to seek out targets for allergic diseases on behalf of Novartis. The ...
Relation and Novartis collaborate to advance treatments for atopic diseases using AI and immuno-dermatology expertise. Relation receives $55 million upfront, with potential milestones up to $1.7 ...
Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...
The future of defense strategy requires restructuring forces for modern threats, focusing deployments on critical regions, accelerating tech integration, reforming procurement and budgets, ...
The Question of Palestinian Statehood: A Conversation With Representative Ro Khanna Representative Ro Khanna discusses whether the United States should recognize Palestine as a sovereign state and the ...
The relationship between cognition and emotion has fascinated Western philosophers for centuries. It is not surprising that much of that attraction has permeated brain science in general. Early ...
At the heart of the deal is Relation’s Lab-in-the-Loop platform, which uses AI models to improve understanding of diseases and guide clinical development programs. Months after securing an approval ...
OSLO, Norway, Dec. 8, 2025 /PRNewswire/ — Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces the presentation of a health economics abstract from the BRAVO study at the Society of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback